2 results match your criteria: "Lund University (A.H.[Affiliation]"
Long-term Impact of Immediate Versus Delayed Treatment of Early Glaucoma: Results From the Early Manifest Glaucoma Trial.
Am J Ophthalmol
August 2023
From the Department of Clinical Sciences, Ophthalmology, Lund University (A.H., D.P., B.B.).
Purpose: To compare long-term visual outcomes in the 2 arms of the Early Manifest Glaucoma Trial (EMGT) and determine if delayed treatment was associated with a penalty in terms of visual function.
Design: Long-term follow-up of a prospective, randomized controlled clinical trial.
Methods: EMGT was carried out at 2 centers in Sweden; 255 subjects with newly detected, untreated glaucoma were randomized to immediate treatment with topical betaxolol and argon laser trabeculoplasty or to no initial treatment as long as no progression was detected.
False Positive Responses in Standard Automated Perimetry.
Am J Ophthalmol
January 2022
From Ophthalmology Research Unit, Department of Clinical Sciences Malmö, Lund University (A.H. and B.B.); Department of Ophthalmology, Skåne University Hospital, Malmö, Sweden (A.H.).
Purpose: To analyze the relationship between rates of false positive (FP) responses and standard automated perimetry results.
Design: Prospective multicenter cross-sectional study.
Methods: One hundred twenty-six patients with manifest or suspect glaucoma were tested with Swedish Interactive Thresholding Algorithm (SITA) Standard, SITA Fast, and SITA Faster at each of 2 visits.